References

American College of Rheumatology Task Force on Osteoporosis Guidelines, 1996. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum., 39: 1791-1801.
Direct Link  |  

Baylink, D.J., 1983. Glucocorticoid-induced osteoporosis. N. Engl. J. Med., 309: 306-308.
PubMed  |  Direct Link  |  

Bergot, C., A.M. Laval-Jeantet and F. Preteux, 1988. Measurement of anisotropic vertebral trabecular bone loss during aging by quantitative image analysis. Calcif. Tissue Int., 43: 143-143.
PubMed  |  

Berkvist, L., H.O. Adami and I. Persson, 1989. The risk of breast cancer after estrogen and estrogenprogestin replacement. N. Engl. J. Med., 321: 293-293.
PubMed  |  Direct Link  |  

Buckley, L.M., E.S. Leib and K.S. Cartularo, 1997. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann. Int. Med., 125: 961-968.
PubMed  |  Direct Link  |  

Chapuy, M.C., M.E. Arlot, F. Duboeuf, J. Brun and B. Crouzet et al., 1992. Vitamin D3 and calcium to prevent hip fractures in elderly women. N. Engl. J. Med., 327: 1637-1642.
PubMed  |  Direct Link  |  

Christian, J.C., P.L. Yu, C.W. Slemenda and C.C.J. Johnston, 1989. Heretability of bone mass: A longitudinal study in aging male twins. Am. J. Hum. Genet., 44: 429-433.
PubMed  |  Direct Link  |  

Colditz, G.A., M.J. Stampfer and W.C. Willett, 1990. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. J. Am. Med. Assoc., 264: 2648-2648.
PubMed  |  Direct Link  |  

Compston, J., 2004. Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis. Osteoporosis Int., 16: S4-S6.
CrossRef  |  

Cummings, S.R., 1985. Are patients with hip fractures more osteoporotic: Review of the evidence. Ann. J. Med., 78: 487-494.
CrossRef  |  

Daniell, H.W., 1976. Osteoporosis of the slender smoker: Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch. Int. Med., 136: 298-304.
PubMed  |  

Eriksen, E.F., P. Charles and F. Melsen, 1993. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation to bone histomorphometry. J. Bone Mineral Res., 8: 127-132.
PubMed  |  Direct Link  |  

Felson, D.T., Y. Zhang and M.T. Hannah, 1993. The effect of postmenopausal estrogen therapy on bone density in elderly women. N. Engl. J. Med., 329: 1141-1146.
PubMed  |  Direct Link  |  

Finklestein, J.S., R.M. Neer and B.M.K. Biller, 1992. Osteopenia in men with a history of delayedpuberty. N. Engl. J. Med., 326: 600-604.
PubMed  |  Direct Link  |  

Geusens, P., J. Nijs and G. van der Perre, 1992. Longitudinal effect on tiludronate on bone mineral density, resonant frequency and strength in monkeys. J. Bone Mineral Res., 7: 599-609.
PubMed  |  Direct Link  |  

Hahn, T.J., L.R. Halstead and S.L. Teitelbau, 1979. Altered mineral metabolism in glucocorticoidinduced osteopenia: Effect of 25-hydroxyvitamin D administration. J. Clin. Invest., 64: 655-665.
CrossRef  |  Direct Link  |  

Jilka, R.L., G. Hangoc, G. Girasole, G. Passeri and D.C. Williams et al., 1992. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science, 257: 88-91.
CrossRef  |  Direct Link  |  

Kelly, T.L., D.M. Slovik and D.A. Schoenfeld, 1988. Quantitative digital radiography versus dual photon absorptiometry of the lumbar spine. J. Clin. Endocrinol. Metab., 67: 839-844.
CrossRef  |  Direct Link  |  

Kloen, P., M. di Paola, O. Borens, J. Richmond and G. Perino et al., 1992. Tumor necrosis factor-alpha inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase-C + blind E. Biochem. Biophys Res. Commun., 182: 341-347.
PubMed  |  Direct Link  |  

Kushida, K., M. Takahashi, K. Kawana and T. Inoue, 1995. Comparison of markers for bone formation andresorption in premenopausal and postmenopausal subjects and osteoporosis patients. J. Clin. Endocrinol. Metab., 80: 2447-2455.
Direct Link  |  

Lafferty, F.W. and M.E. Fiske, 1994. Postmenopausal estrogen replacement: A long term cohort study. Am. J. Med., 97: 66-77.
Direct Link  |  

Lukert, B.P. and L.G. Raisz, 1990. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann. Int. Med., 112: 352-364.
PubMed  |  Direct Link  |  

Manolagas, S.G. and R.L. Jilka, 1995. Bone marrow, cytokines and bone remodeling-Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med., 332: 305-311.
CrossRef  |  Direct Link  |  

Mazzuoli, G.F., M. Passeri and C. Gennari, 1986. Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study. Calcif. Tissue Int., 38: 3-8.
CrossRef  |  Direct Link  |  

Meema, H.E. and S. Meema, 1969. Cortical bone mineral density versus cortical thickness in diagnosis of osteoporosis: A roentgenologic-densitometric study. J. Am. Geriatr. Soc., 17: 120-141.
Direct Link  |  

Melton, I.I.I.L.J. and B.L. Riggs, 1989. Further Characterization of the Heterogeneity of the Osteoporotic Syndromes. In: Clinical Disorders of Bone and Mineral Metabolism, Kleerekoper, M. and S.M. Krane (Eds.). Mary Annual Lieberty, New York, pp: 145.

Melton, L.J., H.W. Wahner and L.S. Richelson, 1986. Osteoporosis and the risk of hip fracture. Am. J. Epidemiol., 124: 154-261.
Direct Link  |  

Melton, L.J., S.R. Cummings and C.C. Johnston, 1987. Heterogeneity of age-related fractures: Implications for epidemiology. Bone Mineral, 2: 321-331.
PubMed  |  Direct Link  |  

Meunier, P.J., C. Roux, E. Seeman, S. Ortolani and J.E. Badurski et al., 2004. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N. Engl. J. Med., 350: 459-468.
CrossRef  |  PubMed  |  

Nagant de Deuxchaisnes, C., 1983. The Pathogenesis and Treatment of Involutional Osteoporosis. In: Osteoporosis, a Multi-Disciplinary Problem, Dixon, A.S.T.J., R.G.G. Russell and T.C.B. Stamp (Eds.). Academic Press, London, pp: 291.

Overgaard, K., 1994. Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose response study. Calcif. Tissue Int., 55: 82-86.
Direct Link  |  

Overgaard, K., B.J. Riis, C. Christinasen and M.A. Hansen, 1989. Effect of salcotonin given intranasally on early postmenopausal bone loss. Br. J. Med., 299: 477-479.
Direct Link  |  

Panigrahi, K., P.D. Delmas and F. Singer, 1994. Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin. Chem., 40: 822-828.
Direct Link  |  

Parfitt, A.M., 1988. Bone Remodeling: Relationship to the Amount and Structure of Bone and the Pathogenesis and Prevention of Fractures. In: Osteoporosis: Etiology, Diagnosis and Management, Riggs, B.L. and I.I.I.L.J. Melton (Eds.). Raven Press, New York, pp: 45.

Parfitt, A.M., C.H.E. Mathews and A.R. Villanueva, 1983. Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. J. Clin. Invest., 72: 1396-1409.

Parfitt, A.M., M.S. Shih and D.S. Rao, 1992. Relationship between bone formation rate and osteoblast surface in aging and osteoporosis: Evidence for impaired osteoblast recruitment in pathogenesis. J. Bone Mineral Res., 1: S116-S116.

Passeri, G., G. Girasole and S. Knutson, 1992. Interleukin-11 IL-11: A new cytokine with osteoclastogenic and bone resorptive properties and a critical role in PTH and 1,25OH2D3-induced osteoclast development. J. Bone Miner. Res., 7: 110-110.

Ramos-Remus, C., J. Sibley and A.S. Russell, 1992. Steroids in rheumatoid arthritis: The honeymoon revisited. J. Rheumatol., 19: 667-667.
Direct Link  |  

Richelson, L.S., W.W. Heinz, L.J. Melton and B.L. Riggs, 1984. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N. Engl. J. Med., 311: 1273-1275.
Direct Link  |  

Riggs, B.L. and I.I.I.L.J. Melton, 1983. Evidence for two distinct syndromes of involutional osteoporosis. Am. J. Med., 75: 899-901.
PubMed  |  Direct Link  |  

Riggs, B.L. and L.J. Melton III, 1986. Involutional osteoporosis. N. Engl. J. Med., 314: 1676-1686.
CrossRef  |  PubMed  |  Direct Link  |  

Riggs, B.L. and L.J. Melton, 1992. The prevention and treatment of osteoporosis. N. Engl. J. Med., 327: 620-627.
PubMed  |  Direct Link  |  

Seeman, E., L. Melton I.I.I and W.M. O`Fallon, 1983. Risk factors for spinal osteoporosis in men. Am. J. Med., 75: 977-983.
Direct Link  |  

Simon, L.S., 2005. Osteoporosis. Clin. Geriatr. Med., 21: 603-629.
Direct Link  |  

Simon, L.S., S.M. Krane and P.D. Wortman, 1984. Serum levels of type I and type III procollagen fragments in Paget`s disease of bone. J. Clin. Endocrinol. Metab., 58: 110-120.
PubMed  |  Direct Link  |  

Singh, M., B.L. Riggs and J.W. Beabout, 1972. Femoral trabecular-pattern index for evaluation of spinal osteoporosis. Ann. Intern. Med., 77: 63-67.
Direct Link  |  

Taylor, A.K., S.A. Lueken and C. Libanati, 1994. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum. Dis. Clin. North Am., 20: 589-607.
Direct Link  |  

Vedi, S., J.E. Compston and A. Webb, 1982. Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects. Metab. Bone Dis. Relat. Res., 4: 231-236.
PubMed  |  Direct Link  |